CALT - Citi downgrades Calliditas to neutral cites takeover offer
2024-05-31 12:09:24 ET
More on Calliditas Therapeutics
- Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q1 2024 Earnings Call Transcript
- Calliditas Therapeutics AB (publ) 2024 Q1 - Results - Earnings Call Presentation
- Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B
- Calliditas Therapeutics: Everest Medicines launches Nefecon in China